Empirically derived combinations of chemotherapeutic drugs have given disappointing results.

For unknown reasons, it is invulnerable to most types of chemotherapeutic drugs that kill other cancer cells.

Specific projects include determining why it sometimes does not work as expected and the process by which some chemotherapeutic drugs activate p53.

There are a number of strategies in the administration of chemotherapeutic drugs used today.

This has been applied to assessing effects of chemotherapeutic drugs.

The enzyme is an important target for certain chemotherapeutic drugs.

Temozolomide is a common chemotherapeutic drug to which oligodendrogliomas appear to be quite sensitive.

It is often used as a first line therapy, especially because of its relatively mild side effects when compared to other chemotherapeutic drugs.

There is evidence to suggest that higher levels of MT expression may also lead to resistance to chemotherapeutic drugs.

A large variety of chemotherapeutic drugs have been developed and commercialised.